Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

4th Annual Hybrid Non-Coding RNA Symposium 2023

Decoding the microRNA mysteries in health and disease

The Annual Hybrid Non-Coding RNA Symposium is a global forum that brings together internationally renowned experts to highlight the latest developments in the field of basic and translational non-coding RNA research. This symposium aims to foster cross-collaborations between national and international researchers/clinicians and serve as a vital platform to accelerate the clinical utility of non-coding RNA-based diagnostics and therapeutics that can pave ways for precision medicine. This meeting will strengthen academia-industry partnership and provide a stimulating environment where students, postdocs and junior investigators can present (oral talk and poster) and discuss their research to a diverse audience. We have included a new session on Cutting-edge technologies highlighting new tools and techniques to study noncoding RNAs and a panel discussion on career development opportunities for the students and junior scientists.

On behalf of the organizers, Dr. Afsar Naqvi (UIC COD) and Dr. Roopa Biswas (USU School of Medicine) and Dr. Victor Ambros (UMass Chan Medical School) we cordially invite noncoding RNA researchers and enthusiasts to participate in this year’s symposium from Wednesday, September 20, 2023 - Friday, September 22, 2023.

Please find details on location, registration dates and pricing, agenda, abstract submission, speaker information, and sponsorship below. If you have urgent questions please contact Dr. Afsar Naqvi directly at afsarraz@uic.edu. If you have any general questions or require more information please email us microRNAsymposium@uic.edu.

Please find our current COVID guidelines here.

This event is now hybrid. Virtual attendee registration is now available.

Register Here

Location Heading link

Location for in-person attendees – UIC Molecular Biology Research Building Auditorium Room 1017 – 900 S. Ashland Ave. Chicago, Illinois 60607

 

Virtual attendees will be provided a Zoom link via email closer to the event.

 

Google Map of 900 S. Ashland Ave.

Plenary Speaker Heading link

N/A

Joshua Mendell MD, PhD
Howard Hughes Medical Institute Investigator
University of Texas Southwestern
“New functions and regulators of noncoding RNAs in mammals”

Joshua Mendell is a clinician scientist, Vice-Chair and Professor in the Department of Molecular Biology and Chair in Medical science at UT Southwestern Medical Center. He completed his MD and PhD in molecular genetics from John Hopkins Medical Center. The Mendell laboratory investigates post-transcriptional gene regulation, noncoding RNA regulation employing high-throughput screening to interrogate dysfunctional pathways in cancer. Mendell lab uncovered the first example of a vertebrate transcription factor that regulates miRNA miR-17-92 cluster expression. Dr. Mendell has been at the forefront of elucidating miRNA functions and translating these findings into novel therapeutic approaches through systemic delivery of miRNAs to potently suppress tumorigenesis in mouse cancer models.

Keynote Speakers Heading link

Headshot

Sandra Wolin MD, PhD 
National Cancer Institute
“Defective RNAs: Surveillance and Roles as Signaling Molecules”

Dr. Sandra Wolin is a physician-scientist specialized in biogenesis, function, and turnover of non-coding RNAs. She heads the section on non-coding RNAs and ribonucleoprotein particles (RNPs) at the National Cancer Institute. Dr. Wolin earned her MD from the Yale School of Medicine and PhD from the department of molecular biophysics and biochemistry at Yale University studying ribonucleoproteins. During her postdoctoral training at the University of California San Francisco, she devised an early ribosome profiling method. Dr. Wolin’s research examines noncoding RNAs functions, cell recognition and degradation of defective RNAs and how failure to degrade these RNAs affects cell function and contributes to human disease. Her lab has identified proteins that recognize misfolded and otherwise defective RNAs.

Headshot

Mark Ansel PhD
University of California San Francisco
“Noncoding RNA circuits in host defense and autoimmunity”

Dr. Mark Ansel is a Professor at the Department of Microbiology & Immunology at University of California San Francisco School of Medicine. Dr. Ansel received his PhD from UCSF and postdoctoral training at the Immune Disease Institute at Harvard Medical School. Dr. Ansel’s lab studies molecular and cellular processes underlying chronic tissue inflammation and dysfunction by examining crosstalk between microRNAs, transcription factors, and epigenetic regulation to shape the gene expression programs that determine lymphocyte development, differentiation, and function in immunity. Dr. Ansel has developed novel biochemical and computational techniques to discover the regulatory information encoded in RNA molecules.

Headshot

Saumya Das MD, PHD 
Harvard Medical School
“Extracellular RNAs: biomarkers and probes for novel disease-related pathways”

Dr. Saumya Das is an Associate Professor of Medicine at Harvard Medical School. Dr. Das completed his MD-PhD at Harvard Medical School and his residency in internal medicine at Massachusetts General Hospital. Das lab focuses on discovering and characterizing plasma RNAs and extracellular vesicles that may serve as biomarkers for disease phenotypes and processes associated with heart failure and left ventricular remodeling. As part of the NIH Extracellular RNA Communication Consortium, Dr. Das has participated in developing new bioinformatics tools and techniques to measure extracellular RNAs and study their functional role in animal and cell culture models.

Register Here

Register Here

Explore Chicago and the UIC Campus Heading link